Healthcare
Live Price
Offline$2.42
-3.97% today
Window Change
-42.17%
Window
Aug 28, 2025 → Jun 1, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 190 bars · Aug 28, 2025 → Jun 1, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
YD Bio Limited Ordinary Shares (YDES) is a Healthcare stock with a market cap of $350.00M and listed on NASDAQ. The stock last traded around $2.42 and down 42.2% across the available one-year price window (Aug 28, 2025 → Jun 1, 2026). Baseline metrics include revenue growth of +45.8%, EPS growth of -280100.0%, a dividend yield of 0.0%. What stands out right now is revenue +45.8%, EPS -280100.0%, free cash flow -8386.3% with operating margin 0.0% and ROIC 13.6%. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines YDES price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
YDES
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
YDES Max Drawdown
-86.74%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for YDES and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.